on Fresenius SE & Co. KGaA (ETR:FRE)
Fresenius Proposes 5% Dividend Increase Amid Strong 2025 Performance
During its 2026 Annual General Meeting, Fresenius SE & Co. KGaA showcased a robust performance for 2025, highlighting its strategic advancements. The healthcare group's success is driven by the #FutureFresenius strategy, particularly the "Rejuvenate" phase, aimed at enhancing innovation and resilience. A proposed 5% dividend increase to €1.05 per share reflects shareholder trust and financial strength.
Despite geopolitical uncertainties, Fresenius maintained financial flexibility and strategic focus. CEO Michael Sen noted the company's achievements, emphasizing balance sheet improvements and sustained investment in innovation. Notably, the company's digitalization efforts include a partnership with SAP to develop an AI-driven healthcare ecosystem.
Research initiatives also progressed, with Fresenius investing over €600 million in R&D annually, impacting areas like biosimilars and medical technology. Through strategic collaboration and innovation, Fresenius reinforces its commitment to future healthcare advancements.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Fresenius SE & Co. KGaA news